To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: APA MEETING: Electromagnetic Stimulation Shows Promise For Treatment-Resistant Depression URL: http://www.pslgroup.com/dg/FE446.htm Doctor's Guide May 17, 1999
WASHINGTON, DC -- May 17, 1999 -- An investigational treatment employing electromagnetic stimulation relieved depression in 25 patients whose depression failed to respond to conventional treatment, report Emory University researchers at this week's American Psychiatric Association meeting. Scores on depression rating scales administered to study subjects before, during and after the new treatment were significantly improved at all time points compared to baseline, said first author Yvonne Greene, M.D., a neurosciences fellow at the Emory University School of Medicine who collaborated on the open trial with William McDonald, M.D., associate professor of psychiatry and behavioural sciences at the Emory University School of Medicine, and others. "Sixty-four percent of patients were rated very much improved or much improved on the [CGIC] Clinical Global Impression of Change and 40 percent of patients had an equal to or greater than 50 percent decrease in HDRS [Hamilton Depression Rating Scale] scores at the end of treatment week two," Green writes. "Forty percent of patients were rated very much improved or much improved on the CGIC and 32 percent of patients had an equal to or greater than 50 percent decrease in HDRS scores at the end of the four-week follow-up. "These results suggest rTMS [repetitive transcranial magnetic stimulation] may be a viable option for patients with treatment-resistant depression." Prior to receiving rTMS, there were an average of seven antidepressant failures per patient and eight patients had failed electroconvulsive therapy, the researchers report. "rTMS involves passing current through an electromagnetic coil to generate a magnetic field," they write. "The magnetic field acts as the medium between electricity in the coil and induced electrical currents in the brain. The current depolarises neurons in the brain up to a depth of about two centimetres below the brain's surface. "Unlike ECT for depression, rTMS does not require anesthesia or analgesics." Study subjects were antidepressant-free for one week prior to rTMS and received 10 daily treatments (10 trains of five seconds each, 25 seconds apart) at a frequency of 10 Hz. Seventy-eight percent of patients experienced mild-moderate discomfort at the site of stimulation, two patients who experienced severe pain in the treatment site dropped out of the study and eight percent of patients experienced a posttreatment headache. The mean age of patients treated was 52 years. "rTMS seems most promising for older adults and for treatment-resistant patients with depression," said Dr. McDonald, who directs the Fuqua Center for Late-Life Depression at Wesley Woods. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.